Results 191 to 200 of about 5,010 (218)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Genetic Insights into Peripheral Artery Disease: A Narrative Review. [PDF]

open access: yesBiomedicines
Pérez-Hernández N   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Kamalaśīla’s Views on Dependent Origination

Asiatische Studien, 2023
Vincent Eltschinger
exaly  

Mass extinctions alter extinction and origination dynamics with respect to body size

Proceedings of the Royal Society B: Biological Sciences, 2021
Pedro M Monarrez   +2 more
exaly  

Home - About - Disclaimer - Privacy